Characteristic and health risk of per- and polyfluoroalkyl substances from cosmetics via dermal exposure
Environmental Pollution · 2023-12 · 338 · 122685
DOI: 10.1016/j.envpol.2023.122685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Pollution, 2023-12. Verfasst von Xia Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, PR China. Hauptthemen laut MEDLINE: Fluorocarbons, Alkanesulfonic Acids. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
In this work, 45 cosmetic samples were collected from China, and 27 target per- and polyfluoroalkyl substances (PFAS) were analyzed by ultrahigh-performance liquid chromatography-high resolution mass spectrometry. PFAS were found in all samples, including the products marketed for pregnant women, and the total concentrations of PFAS measured in each sample were in the range of 4.05 - 94.9 ng/g. Short-chain perfluorinated carboxylic acids were the dominant compounds contributing to over 60% of the total content. Perfluorobutanoic acid, with high placental transfer efficiency, was the major PFAS in cosmetics for pregnant women. Three emerging PFAS, 2-perfluorohexyl ethanoic acid, 3-perfluoropentyl propanoic acid (5:3) and perfluoro-2-propoxypropanoic acid, were also identified in the cosmetic samples at quantifiable levels. Significantly, positive correlations between individual PFAS were observed, indicating that there may be a common source for PFAS in these samples. Statistical analyses suggested that using plastic containers and precursor substances may be potential sources of PFAS in terminal products, and product aging may increase PFAS levels. From the PFAS analysis of the cosmetics, the margin of safety (MoS) and hazard quotient (HQ) were calculated to assess human health risks through dermal exposure by using these products. Although the MoS and HQ values obtained were deemed acceptable, the cumulative effect caused by composite and long-term exposure to these contaminants needs to be given greater attention by health authorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, PR China.
- Department of Gynecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China.
- Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, PR China. Electronic address: zzhuang@whu.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Lin, X., Xing, Y., Chen, H., Zhou, Y., Zhang, X., Liu, P., Li, J., Lee, H. K., & Huang, Z. (2023). Characteristic and health risk of per- and polyfluoroalkyl substances from cosmetics via dermal exposure. Environmental Pollution, 338, 122685. https://doi.org/10.1016/j.envpol.2023.122685
Vancouver
Lin X, Xing Y, Chen H, Zhou Y, Zhang X, Liu P, et al. Characteristic and health risk of per- and polyfluoroalkyl substances from cosmetics via dermal exposure. Environmental Pollution. 2023;338:122685. doi:10.1016/j.envpol.2023.122685
BibTeX
@article{Lin2023,
author = {Lin, Xia and Xing, Yudong and Chen, Huijun and Zhou, Yan and Zhang, Xin and Liu, Peng and Li, Jiaoyang and Lee, Hian Kee and Huang, Zhenzhen},
title = {Characteristic and health risk of per- and polyfluoroalkyl substances from cosmetics via dermal exposure},
journal = {Environmental Pollution},
year = {2023},
volume = {338},
pages = {122685},
doi = {10.1016/j.envpol.2023.122685}
}
EUVIMED